Microbot Medical acquires Nitiloop's assets, including FDA-cleared microcatheters
#Acquisition
Apr 7, 2020
www.prnewswire.com
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
#Investment
Oct 26, 2017
www.prnewswire.com
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
#Customers
May 18, 2015
www.businesswire.com
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
Microbot Medical acquires Nitiloop's assets, including FDA-cleared microcatheters
#Acquisition
Apr 7, 2020
www.prnewswire.com
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
#Investment
Oct 26, 2017
www.prnewswire.com
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
#Customers
May 18, 2015
www.businesswire.com
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature